Albany International Corporation
AIN Consumer Cyclical Textile Manufacturing
Albany International Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 3.88% from fiscal 2024.
- Revenue
- +33.7%
- EPS
- +143.6%
- Free cash flow
- +42.2%
- Total debt
- −12.2%
Quarter to September 2026, against a year earlier
Follow AIN
Alert me
Albany International Corporation (AIN) P/B ratio
As of 5 November 2026, Albany International Corporation (AIN) trades at a P/B ratio of 2.4×. Over the past ten years it has ranged from 1.5× (March 2020) to 4.5× (September 2019); the current reading is higher than 24% of that period. That is above the Consumer Cyclical sector median of 1.7×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 2.0× | (22.20%) |
| FY2024 | 2.6× | (16.09%) |
| FY2023 | 3.1× | (12.64%) |
| FY2022 | 3.6× | 10.14% |
| FY2021 | 3.3× | 12.61% |
| FY2020 | 2.9× | (17.03%) |
| FY2019 | 3.5× | 5.41% |
| FY2018 | 3.3× | (4.98%) |
| FY2017 | 3.5× | 17.73% |
| FY2016 | 3.0× | 27.23% |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 2.1× | (23.60%) |
| Jun 2026 | 2.8× | 39.73% |
| Mar 2026 | 2.0× | (1.80%) |
| Dec 2025 | 2.0× | (1.35%) |
| 43 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| PASW Ping An Biomedical Co., Ltd. compare | n/m |
| SMJF SMJ International Holdings Inc. compare | n/m |
| UFI Unifi, Inc. compare | 0.5× |
| DXYN The Dixie Group, Inc. compare | 0.5× |
| CULP Culp, Inc. compare | 0.8× |
| AIN Albany International Corporation | 2.4× |
| Consumer Cyclical sector median | 1.7× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on AIN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement